Clear Search sequence regions


Sizes of these terms reflect their relevance to your search.

Oral squamous cell carcinoma (OSCC) is a prevalent malignancy affecting the head and neck region. The prognosis for OSCC patients remains unfavorable due to the absence of precise and efficient early diagnostic techniques. Metabolomics offers a promising approach for identifying distinct metabolites, thereby facilitating early detection and treatment of OSCC. This review aims to provide a comprehensive overview of recent advancements in metabolic marker identification for early OSCC diagnosis. Additionally, the clinical significance and potential applications of metabolic markers for the management of OSCC are discussed. This review summarizes metabolic changes during the occurrence and development of oral squamous cell carcinoma and reviews prospects for the clinical application of characteristic, differential metabolites in saliva, serum, and OSCC tissue. In this review, the application of metabolomic technology in OSCC research was summarized, and future research directions were proposed. Metabolomics, detection technology that is the closest to phenotype, can efficiently identify differential metabolites. Combined with statistical data analyses and artificial intelligence technology, it can rapidly screen characteristic biomarkers for early diagnosis, treatment, and prognosis evaluations. © 2024 Wiley Periodicals LLC.

Citation

Guanfa Luo, Shuai Wang, Wen Lu, Wei Ju, Jianhong Li, Xiao Tan, Huiting Zhao, Wei Han, Xihu Yang. Application of metabolomics in oral squamous cell carcinoma. Oral diseases. 2024 Sep;30(6):3719-3731

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 38376209

View Full Text